Inhibition of avian myeloblastosis virus reverse transcriptase and virus inactivation by metal complexes of isonicotinic acid hydrazide.
The cupric and ferric complexes of isonicotinic acid hydrazide (INH) inhibit the DNA synthesis catalysed by avian myeloblastosis virus (AMV) reverse transcriptase. The inhibition was to the extent of 95% by 50 microM of cupric-INH complex and 55% by 100 microM of ferric-INH complex. These complexes have been found to bind preferentially to the enzyme than to the template-primer. Kinetic analysis showed that the cupric-INH complex is a non-competitive inhibitor with respect to dTTP. The time course of inhibition has revealed that the complexes are inhibitory even after the initiation of polynucleotide synthesis. In vivo toxicity studies in 1-day-old chicks have shown that the complexes are not toxic up to a concentration of 500 microgram per chick. Infection of the 1-day-old chicks with AMV pretreated with 150 microgram of either of the complexes prevented symptoms of leukemia due to virus inactivation.
D000818:Animals; D001353:Avian Leukosis / Q000517:prevention & control; D001354:Avian Leukosis Virus / Q000187:drug effects*; D009189:Avian Myeloblastosis Virus / Q000187:drug effects* / Q000201:enzymology; D001667:Binding, Competitive; D002645:Chickens; D003300:Copper / Q000494:pharmacology* / Q000633:toxicity; D004279:DNA, Viral / Q000096:biosynthesis; D004305:Dose-Response Relationship, Drug; D005290:Ferric Compounds / Q000494:pharmacology* / Q000633:toxicity; D007501:Iron / Q000494:pharmacology*; D007538:Isoniazid / Q000494:pharmacology* / Q000633:toxicity; D018894:Reverse Transcriptase Inhibitors; D014764:Viral Proteins / Q000037:antagonists & inhibitors*; D014779:Virus Replication / Q000187:drug effects*
D004279:DNA, Viral; D005290:Ferric Compounds; D018894:Reverse Transcriptase Inhibitors; D014764:Viral Proteins; D003300:Copper; D007501:Iron; D007538:Isoniazid